Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Gastroenterology

Issue Information

Alimentary Pharmacology and Therapeutics

English

Systematic Review: Quality of Trials on the Symptomatic Effects of the Low FODMAP Diet for Irritable Bowel Syndrome

Alimentary Pharmacology and Therapeutics

English

Letter: The Safety of Herpes Zoster Vaccination for Patients With Inflammatory Bowel Disease Being Treated With Anti-TNF Medications-Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Letter: Programmed Cell Death Protein-1 (PD-1)-targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data From an International Multicentre Real-World Cohort-More Questions Than Answers

Alimentary Pharmacology and Therapeutics

English

Letter: Changes in FIB-4 Cut-Off Points for Viral Hepatitis

Alimentary Pharmacology and Therapeutics

English

Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded

Alimentary Pharmacology and Therapeutics

English

High Incidence of Autoimmune Gastritis in Patients Misdiagnosed With Two or More Failures of H. Pylori Eradication

Alimentary Pharmacology and Therapeutics

English

Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy

Alimentary Pharmacology and Therapeutics

English

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Alimentary Pharmacology and Therapeutics

English

Editorial: De Novo Inflammatory Bowel Disease Following Bariatric Surgery-Potential Implications for Research and Clinical Practice. Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Gastroenterology

Issue Information

Systematic Review: Quality of Trials on the Symptomatic Effects of the Low FODMAP Diet for Irritable Bowel Syndrome

Letter: The Safety of Herpes Zoster Vaccination for Patients With Inflammatory Bowel Disease Being Treated With Anti-TNF Medications-Authors’ Reply

Letter: Programmed Cell Death Protein-1 (PD-1)-targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data From an International Multicentre Real-World Cohort-More Questions Than Answers

Letter: Changes in FIB-4 Cut-Off Points for Viral Hepatitis

Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded

High Incidence of Autoimmune Gastritis in Patients Misdiagnosed With Two or More Failures of H. Pylori Eradication

Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Editorial: De Novo Inflammatory Bowel Disease Following Bariatric Surgery-Potential Implications for Research and Clinical Practice. Authors’ Reply